 Home > Biochemistry News > Biotechnology News > mRNA cancer vaccine obtains FDA fast track qualification to treat melanoma

mRNA cancer vaccine obtains FDA fast track qualification to treat melanoma

 Last Update: 2021-12-01
 Source: Internet
 Author: User

Tags

advanced materials journal

monoclonal antibody drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 19, 2021, BioNTech announced that the US FDA has granted BNT111 Fast Track status

BioNTech’s FixVac technology platform uses mRNA to express shared tumor-associated antigens, which can target antigen-presenting cells and activate antigen-specific T cell responses

▲Introduction to FixVac technology platform (picture source: BioNTech official website)

BNT111 is a ready-to-use therapeutic vaccine manufactured using the FixVac technology platform

▲BNT111 has shown gratifying results in phase 1 clinical trials (Image source: BioNTech official website)

This phase 2 clinical trial aims to evaluate the efficacy of BNT111 in combination with the anti-PD-1 monoclonal antibody drug Libtayo (cemiplimab)

“The FDA’s grant of Fast Track status underscores the potential of our FixVac platform, which is expected to solve the current treatment challenges faced by melanoma patients

Reference materials:

[1] BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.